Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
13m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
39m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
39m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
39m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
40m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning
Biocryst Pharmaceuticals Inc logo

Biocryst Pharmaceuticals Inc

About

Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 15 2026
BioCryst to Report First Quarter 2026 Financial Results on May 6
Apr 6 2026
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
Feb 26 2026
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update
Feb 11 2026
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting
Feb 5 2026
BioCryst to Report Fourth Quarter 2025 Financial Results on February 26

Financials

Revenue
$874.84 M
Market Cap
$2.26 B
P/E Ratio
7.45
EPS
1.21

Community Chat

Ask AI

6ix6ixAIEvents